New research has investigated the mechanism by which bivalency functions to poise genes for expression during cell differentiation, providing insight into a long-standing paradigm in the regulation of ...

Researchers uncover key mechanisms in gene regulation that may lead to better design of RNA-based medicines.

In this manuscript, we give an overview of historical aspects, as well as the current state of clinical trials and approved gene therapy products for commercialization in Brazil. Focusing on gene ...

Corp., a clinical-stage biotechnology company discovering and developing cell and gene immunotherapies for solid and hematological malignancies, is presenting clinical data from a completed Phase 1 ...

Elevidys, a product developed by Sarepta Therapeutics Inc., scrupulously treats Duchenne muscular dystrophy DMD by delivering a micro-dystrophin gene to muscle cells, partially restoring ...

(IN BRIEF) The German Academic Exchange Service (DAAD) has launched its Strategy 2030 to address significant geopolitical changes and strengthen Germany’s position as a leader in global academia. The ...

While DMD is currently incurable, hope lies in emerging treatments like ELEVIDYS (Delandistrogene Moxeparvovec Rokl), a gene therapy designed to help the muscles produce dystrophin. However ...

We have reached the halfway point of the January transfer window and several sagas are coming to a head. Arsenal and Mikel Arteta are keen to add a new striker this month after Gabriel Jesus was ...

REGENXBIO's partnership with Nippon Shinyaku provides $110M upfront, ensuring a cash runway for gene therapy programs in MPS I & II, despite sacrificing some upside. REGENXBIO is rated a HOLD ...

Join us for the latest transfer news, rumors and gossip from around the globe. Transfers homepage | Done deals | Men's January grades | Women's January grades - Sources: Fire among 3 MLS teams in ...